ORIC Pharmaceuticals, Inc. (ORIC) Financials

ORIC Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 436.8 million 21.2 million
Dec. 31, 2025 411.0 million 26.6 million
Sept. 30, 2025 431.2 million 24.3 million
June 30, 2025 346.9 million 22.9 million

ORIC Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -32.4 million 6.9 million
Dec. 31, 2025 -22.9 million 6.3 million
Sept. 30, 2025 -25.1 million 5.6 million
June 30, 2025 -30.9 million 6.6 million

ORIC Net Income

No data available :(

ORIC Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 281.9 million - 3.3 million
Dec. 31, 2025 281.5 million 4.1 million 4.1 million
Sept. 30, 2025 287.1 million - 3.3 million
June 30, 2025 282.5 million - 3.3 million

ORIC Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 105.5 million
Dec. 31, 2025 87.8 million
Sept. 30, 2025 99.0 million
June 30, 2025 78.1 million

ORIC Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 2000 31.4 million 8.2 million -
Dec. 31, 2025 387000 25.9 million 8.7 million -
Sept. 30, 2025 35000 28.8 million 7.9 million -
June 30, 2025 63000 30.5 million 8.5 million -

ORIC Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - -
Dec. 31, 2025 - 320000
Sept. 30, 2025 - -
June 30, 2025 - 310000

ORIC

Price: $8.39

52 week price:
7.23
14.93

Earnings Per Share: -1.39 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 145300

Market Capitalization: 830.2 million

Links: